Akanda to Acquire Portugal-based Holigen, Securing a Cannabis Sector Leadership Position in Europe, the Middle East and Africa (EMEA) with EU GMP Market Access
April 20, 2022
Transformational deal will add prized cultivation, manufacturing and distribution assets to accelerate Akanda’s seed-to-patient model and satisfy demand in fast-growing European cannabis […]
Akanda Corp. Announces Pricing of Initial Public Offering
April 14, 2022
LONDON–(BUSINESS WIRE)–Akanda Corp. (“Akanda” or the “Company”), an international medical cannabis company, today announced the pricing of its initial public offering of […]
Akanda Corp. Closes Initial Public Offering
March 17, 2022
LONDON–(BUSINESS WIRE)– Akanda Corp. (“Akanda” or the “Company”), an international medical cannabis company, today announced the completion of its initial public offering of […]
Akanda Corp. Common Shares Set to Commence Trading Today on Nasdaq Under Ticker Symbol “AKAN”
March 15, 2022
LONDON–(BUSINESS WIRE)– Akanda Corp (NASDAQ: AKAN) (“Akanda” or the “Company”), an international medical cannabis company, today announced the Company’s common shares are scheduled […]
Akanda Corp. Closes Its First Day of Trading on The NASDAQ Capital Market
March 15, 2022
LONDON–(BUSINESS WIRE)– Akanda Corp. (NASDAQ: AKAN) (“Akanda” or the “Company”), an international medical cannabis company, today commenced the trading of its common shares […]
Akanda Corp. Names Dr. Sunny Nayee as U.K. Medical Director to Support Partnership with Cellen Life Sciences
February 15, 2022
Expert in Chronic Pain Management Joins International Medical Cannabis Company LONDON–(BUSINESS WIRE)–International medical cannabis company Akanda Corp. (“Akanda” or the “Company”) today […]
Akanda Corp. Names Gila Jones, Gugu Dingaan and Bridget Baker to Board of Directors
February 10, 2022
Dynamic Group of Accomplished Women Round Out Leadership Team LONDON–(BUSINESS WIRE)–Akanda Corp. (“Akanda” or the “Company”) today announced the appointment of Gila […]
Akanda Corp. Announces Confidential Submission of Draft Registration Statement for Proposed Initial Public Offering
November 19, 2021
LONDON–(BUSINESS WIRE)–International medical cannabis company Akanda Corp. (“Akanda” or the “Company”) today announced that it has submitted a confidential draft registration statement […]
Akanda Corp. Closes $5 Million Private Placement
November 17, 2021
LONDON–(BUSINESS WIRE)–Akanda Corp. (“Akanda” or the “Company”) today announced that it has closed a private placement for aggregate gross proceeds of $5,316,000. […]
Akanda’s CanMart Subsidiary to Distribute Award-Winning Cannim Cannabis Products to UK Patients
November 16, 2021
LONDON–(BUSINESS WIRE)–Akanda Corp. (“Akanda” or the “Company”) today announced that its wholly-owned subsidiary, CanMart Ltd. (“CanMart”), has entered into a distribution agreement […]
Akanda Corp Acquires Bophelo and CanMart from Halo Collective Creating a Leading International Medical Cannabis Company
November 10, 2021
LONDON–(BUSINESS WIRE)–Akanda Corp. (“Akanda” or the “Company”) today announced that it has completed the acquisition of Bophelo Bio Science & Wellness (Pty) […]
Akanda Corp Names Dr. Aslihan Akkar-Schenkl President
November 10, 2021
LONDON–(BUSINESS WIRE)–Akanda Corp. (“Akanda”) today announced that Dr. Aslihan Akkar-Schenkl, an experienced executive in the cannabis industry, a registered pharmacist and European […]